Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Cash from Financing Activities (2020 - 2025)

Alignment Healthcare's Cash from Financing Activities history spans 6 years, with the latest figure at $15.3 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 85.69% year-over-year to $15.3 million; the TTM value through Dec 2025 reached $18.0 million, down 88.44%, while the annual FY2025 figure was $18.0 million, 88.44% down from the prior year.
  • Cash from Financing Activities reached $15.3 million in Q4 2025 per ALHC's latest filing, up from $948000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $363.7 million in Q1 2021 to a low of -$3.5 million in Q2 2021.
  • Average Cash from Financing Activities over 5 years is $36.7 million, with a median of $181000.0 recorded in 2025.
  • The largest YoY upside for Cash from Financing Activities was 237400.0% in 2024 against a maximum downside of 1216.67% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$3.5 million in 2021, then soared by 85.07% to -$527000.0 in 2022, then skyrocketed by 108.54% to $45000.0 in 2023, then soared by 237400.0% to $106.9 million in 2024, then plummeted by 85.69% to $15.3 million in 2025.
  • Per Business Quant, the three most recent readings for ALHC's Cash from Financing Activities are $15.3 million (Q4 2025), $948000.0 (Q3 2025), and $1.6 million (Q2 2025).